TGA Approval

MESALAZINE SCP mesalazine 1.2 g gastro-resistant prolonged release tablet bottle (310312)

ARTG ID

310312

ARTG Name

MESALAZINE SCP mesalazine 1.2 g gastro-resistant prolonged release tablet bottle

Sponsor

Southern Cross Pharma Pty Ltd

ARTG Date

September 2, 2021

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

SOUTHERN CROSS PHARMA PTY LTD

Ingredient Name

mesalazine

Empowering clinical research with data-driven insights and AI-powered tools.

MESALAZINE SCP mesalazine 1.2 g gastro-resistant prolonged release tablet bottle (310312) - TGA 批准文号 | MedPath